Exploring cancer maps
Melanoma is a somewhat unusual cancer—one that blooms before our very eyes, often on sun-exposed skin, and can quickly become deadly as it turns our own skin against us and spreads to other organs.
Apr 14, 2022
0
52
Melanoma is a somewhat unusual cancer—one that blooms before our very eyes, often on sun-exposed skin, and can quickly become deadly as it turns our own skin against us and spreads to other organs.
Apr 14, 2022
0
52
Primary care-based melanoma screening is associated with increased detection of thin melanomas, according to a study published online April 6 in JAMA Dermatology.
Apr 6, 2022
0
4
The global burden of melanoma is considerable and is expected to increase by 2040, according to a study published online March 30 in JAMA Dermatology.
Mar 30, 2022
0
2
For patients with previously untreated metastatic or unresectable melanoma, the combination of relatlimab + nivolumab continues to demonstrate a progression-free survival (PFS) benefit over nivolumab alone, according to updated ...
Mar 21, 2022
0
13
Acral melanoma is a rare subtype that represents roughly 3% of all melanoma cases. Unlike typical melanoma that occurs on sun-exposed skin, acral melanoma develops on the nonhair bearing skin of the soles, palm and nail beds. ...
Mar 11, 2022
0
68
For years, surgery for patients with stage III melanoma—melanoma that has spread to the lymph nodes—involved removing those lymph nodes along with the primary tumor. Known as completion lymph node dissection (CLND), the ...
Mar 4, 2022
0
4
Melanoma patients receiving therapy that helps their immune system kill cancer cells respond to treatment differently depending on the types of microbes in their gut, and new research suggests the microorganisms hindering ...
Feb 28, 2022
0
142
With the new year underway, many people are looking to improve their health. One way they can do that is to reduce their chance of melanoma by understanding potential risk factors.
Feb 1, 2022
0
9
A pioneering test which reliably predicts the spread or return of the most deadly form of skin cancer has been developed by a team of Newcastle scientists and clinicians.
Jan 14, 2022
0
28
In patients with untreated, advanced melanoma, the combination of immune checkpoint inhibitors relatlimab and nivolumab doubled the progression-free survival benefit compared to nivolumab alone, with a manageable safety profile, ...
Jan 5, 2022
0
56